Clinical Trial Update: Phase 4 Study to Evaluate Treatment Optimization With Once-daily Insulin Glargine 300 U/mL [Phase 4]

View source ↗

Summary

Phase 4 trial updating treatment optimization with once-daily insulin glargine 300 U/mL in Type I diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• insulin glargine 300 U/mL (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Type I Diabetes Mellitus | Phase 4 | Status: COMPLETED